ESC Premium Access

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Congress Presentation

About the speaker

Doctor Arzu Kalayci Karabay

Harvard Medical School, Boston (United States of America)
0 follower

3 more presentations in this session

State of the Art - Optimizing the prevention of venous thromboembolism

Speaker: Professor A. Spyropoulos (New York, US)


Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Speaker: Doctor Y. Yamashita (Kyoto, JP)


Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Speaker: Doctor E. Klok (Leiden, NL)


Access the full session

Progress in anticoagulation for venous thromboembolism

Speakers: Doctor A. Kalayci Karabay, Professor A. Spyropoulos, Doctor Y. Yamashita, Doctor E. Klok

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb